Treatment Shows Sustained Benefit in Larger Group of Beta Thalassemia Patients Treatment Shows Sustained Benefit in Larger Group of Beta Thalassemia Patients

New results for Bluebird Bio Inc. ' s LentiGlobin treatment for beta thalassemia continue to look promising.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news